These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

548 related items for PubMed ID: 31550776

  • 1. [Different effects of pravastatin on sFlt-1, PlGF and VEGF in different preeclampsia-like mouse models].
    Xiang QQ, Yang Z, Huai J, Wang GJ.
    Zhonghua Fu Chan Ke Za Zhi; 2019 Sep 25; 54(9):601-607. PubMed ID: 31550776
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Role of mammalian target of rapamycin signaling pathway in regulation of fatty acid oxidation in a preeclampsia-like mouse model treated with pravastatin.
    Huai J, Yang Z, Yi YH, Wang GJ.
    Chin Med J (Engl); 2019 Mar 20; 132(6):671-679. PubMed ID: 30855348
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Effects of pravastatin on angiogenic and placental hypoxic imbalance in a mouse model of preeclampsia.
    Saad AF, Kechichian T, Yin H, Sbrana E, Longo M, Wen M, Tamayo E, Hankins GD, Saade GR, Costantine MM.
    Reprod Sci; 2014 Jan 20; 21(1):138-45. PubMed ID: 23749761
    [Abstract] [Full Text] [Related]

  • 6. Different Effects of Pravastatin on Preeclampsia-like Symptoms in Different Mouse Models.
    Huai J, Yang Z, Yi YH, Wang GJ.
    Chin Med J (Engl); 2018 Feb 20; 131(4):461-470. PubMed ID: 29451152
    [Abstract] [Full Text] [Related]

  • 7. Contrasting effects of chronic hypoxia and nitric oxide synthase inhibition on circulating angiogenic factors in a rat model of growth restriction.
    Bahtiyar MO, Buhimschi C, Ravishankar V, Copel J, Norwitz E, Julien S, Guller S, Buhimschi IA.
    Am J Obstet Gynecol; 2007 Jan 20; 196(1):72.e1-6. PubMed ID: 17240241
    [Abstract] [Full Text] [Related]

  • 8. Longitudinal changes in maternal serum placental growth factor and soluble fms-like tyrosine kinase-1 in women at increased risk of pre-eclampsia.
    Khalil A, Maiz N, Garcia-Mandujano R, Penco JM, Nicolaides KH.
    Ultrasound Obstet Gynecol; 2016 Mar 20; 47(3):324-31. PubMed ID: 26387758
    [Abstract] [Full Text] [Related]

  • 9. Soluble fms-like tyrosine kinase-1 and placental growth factor kinetics during and after pregnancy in women with suspected or confirmed pre-eclampsia.
    Saleh L, van den Meiracker AH, Geensen R, Kaya A, Roeters van Lennep JE, Duvekot JJ, Verdonk K, Steegers EAP, Russcher H, Danser AHJ, Visser W.
    Ultrasound Obstet Gynecol; 2018 Jun 20; 51(6):751-757. PubMed ID: 28600845
    [Abstract] [Full Text] [Related]

  • 10. Effects of sirtuin 1 deficiency on trophoblasts and its implications in the pathogenesis of pre-eclampsia.
    Yu H, Chen L, Du P, Liu X, Xia Y.
    J Obstet Gynaecol; 2023 Dec 20; 43(2):2282103. PubMed ID: 37966393
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Variation of long-chain 3-hydroxyacyl-CoA dehydrogenase DNA methylation in placenta of different preeclampsia-like mouse models].
    Han Y, Yang Z, Ding X, Yu H, Yi Y.
    Zhonghua Fu Chan Ke Za Zhi; 2015 Oct 20; 50(10):740-6. PubMed ID: 26675572
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Association between angiogenic factors and signs of arterial aging in women with pre-eclampsia.
    Akhter T, Wikström AK, Larsson M, Larsson A, Wikström G, Naessen T.
    Ultrasound Obstet Gynecol; 2017 Jul 20; 50(1):93-99. PubMed ID: 27256927
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Placental Growth Factor Administration Abolishes Placental Ischemia-Induced Hypertension.
    Spradley FT, Tan AY, Joo WS, Daniels G, Kussie P, Karumanchi SA, Granger JP.
    Hypertension; 2016 Apr 20; 67(4):740-7. PubMed ID: 26831193
    [Abstract] [Full Text] [Related]

  • 19. A longitudinal study of circulating angiogenic and antiangiogenic factors and AT1-AA levels in preeclampsia.
    Sahay AS, Patil VV, Sundrani DP, Joshi AA, Wagh GN, Gupte SA, Joshi SR.
    Hypertens Res; 2014 Aug 20; 37(8):753-8. PubMed ID: 24718301
    [Abstract] [Full Text] [Related]

  • 20. The role of angiogenic, anti-angiogenic and vasoactive factors in pre-eclamptic African women: early- versus late-onset pre-eclampsia.
    Govender L, Mackraj I, Gathiram P, Moodley J.
    Cardiovasc J Afr; 2012 Apr 20; 23(3):153-9. PubMed ID: 22555639
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.